期刊
FUTURE ONCOLOGY
卷 11, 期 16, 页码 2263-2266出版社
FUTURE MEDICINE LTD
DOI: 10.2217/fon.15.161
关键词
HCC; multikinase inhibitors; RAS; RAF; MEK; ERK pathway; sorafenib